Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | PAOX | Q6QHF9 | 5/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | HBB | P68871 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 3/20 | 0.36 |
| ▸ | CES1 | P23141 | 3/20 | 0.36 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6839720 | 1.00 | ALDH1A1 (0.54) | ALDH1A1PAOXLMNAMEN1BLM | |
| SCHEMBL3022984 | 0.98 | ALDH1A1 (0.50) | ALDH1A1PAOXLMNAMEN1BLM | |
| SCHEMBL856486 | 0.91 | — | — | |
| SCHEMBL9680510 | 0.81 | ALDH1A1 (0.52) | ALDH1A1LMNAMEN1BLMHBB | |
| SCHEMBL2999774 | 0.80 | — | — | |
| SCHEMBL11701621 | 0.79 | LMNA (0.65) | ALDH1A1LMNAMEN1BLMHBB | |
| SCHEMBL2380101 | 0.79 | LMNA (0.65) | ALDH1A1LMNAMEN1BLMHBB | |
| SCHEMBL1119124 | 0.79 | LMNA (0.65) | ALDH1A1LMNAMEN1BLMHBB | |
| SCHEMBL2372027 | 0.79 | LMNA (0.65) | ALDH1A1LMNAMEN1BLMHBB | |
| SCHEMBL11879024 | 0.79 | ALDH1A1 (0.50) | ALDH1A1LMNAMEN1BLMHBB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8540966-B2 | Contrast agents endowed with high relaxivity | BRACCO IMAGING S.P.A. (IT) | 2013-09-24 | — | — | US | disclosed |
| US-20110256067-A1 | Contrast agents endowed with high relaxivity | BRACCO IMAGING SPA (IT) | 2011-10-20 | — | — | US | disclosed |
| US-5207876-A | Ketone, ether or ester extraction agents | Berg, Lloyd (US) | 1993-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110256067-A1 | Contrast agents endowed with high relaxivity | SLC40A1, SLC67A1, SLC19A1 | ALDH1A1 2186/4885PAOX 2012/4885LMNA 2401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.